Stem cell study could pave the way to treatment for age-related muscle wasting

Scientists world wide are racing to pin down the complex molecular processes that cause stem cells in the early embryo to differentiate into specialist cells such as muscle or nerve cells. The field has the potential to revolutionzse medicine by delivering therapies to regenerate tissue damaged by disease or injury.

Differentiation happens soon after fertilization, when embryonic cells are dividing rapidly and migrating as the animal's body takes shape.

Professor Marcelle's team analyzed the differentiation of muscle stem cells in chicken embryos. The mechanisms in birds are identical to those in mammals, so the chick is a good model species for understanding the mechanisms in humans, says team member and the paper's lead author, Anne Rios.

The scientists investigated the effect of a known signaling pathway called NOTCH on muscle differentiation. They found that differentiation of stem cells to muscle was initiated when NOTCH signaling proteins touched some of the cells. These proteins were carried by passing cells migrating from a different tissue-the neural crest-the progenitor tissue of sensory nerve cells. Muscle formation in the target stem cells occurred only when the NOTCH pathway was triggered briefly by the migrating neural crest cells.

"This kiss-and-run activation of a pathway is a completely novel mechanism of stem cell specification which explains why only some stem cells adopt a muscle cell fate," Ms Rios said.

Professor Marcelle said that more than 2 per cent of the population was affected by muscle dysfunction. "Muscle frailty in aging and disease imposes a huge economic burden, so it is critical to explore novel avenues of research that could lead to new treatments," he said.

He said the team would now focus on unraveling the mechanisms of embryonic muscle cell differentiation at the molecular level as a necessary step to regulating regeneration of the muscles in human patients.